Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2008(17): 2835-2839
DOI: 10.1055/s-2008-1067224
DOI: 10.1055/s-2008-1067224
PSP
© Georg Thieme Verlag
Stuttgart ˙ New York
Direct Synthesis of Protected Enantiopure 5-Cyano-3,4-dihydroxypyrrolidin-2-ones from β-Lactam Aldehydes Catalyzed by Iodine
Further Information
Received
11 June 2008
Publication Date:
11 August 2008 (online)
Publication History
Publication Date:
11 August 2008 (online)
Abstract
A single-step catalytic ring-expansion approach from 4-oxoazetidine-2-carbaldehydes to protected enantiopure 5-cyano-3,4-dihydroxypyrrolidin-2-ones has been achieved by the use of the commercially available and inexpensive reagent, molecular iodine, in the presence of tert-butyldimethyl cyanide. Interestingly, the catalyst directs the reaction toward the selective rearrangement reaction of the β-lactam nucleus rather than cyanohydrin formation.
Key words
catalysis - iodine - β-lactams - pyrrolidines - ring expansion
-
1a
Compain P.Martin OR. Iminosugars: From Synthesis to Therapeutic Applications Wiley; Chichester: 2007. -
1b
Curtis KL.Evinson EL.Handa S.Singh K. Org. Biomol. Chem. 2007, 5: 3544 -
1c
Asano N. Glycobiology 2003, 13: 93R -
1d
Nishimura Y. Curr. Top. Med. Chem. 2003, 3: 575 -
1e
Asano N.Nash RJ.Molyneux RJ.Fleet GWJ. Tetrahedron: Asymmetry 2000, 11: 1645 -
1f
Legler G. In Iminosugars as Glycosidase Inhibitors: Nojirimycin and BeyondStütz AE. Wiley-VCH; Weinheim: 1999. - 2 For a seminal review, see:
Nájera C.Yus M. Tetrahedron: Asymmetry 1999, 10: 2245 - For antibiotic use, see:
-
3a
Southgate R.Branch C.Coulton S.Hunt E. In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products Vol. 2:Lukacs G. Springer; Berlin: 1993. p.621 -
3b
Chemistry
and Biology of β-Lactam Antibiotics
Vol.
1-3:
Morin RB.Gorman M. Academic; New York: 1982. - For enzyme inhibition use, see:
-
3c
Veinberg G.Vorona M.Shestakova I.Kanepe I.Lukevics E. Curr. Med. Chem. 2003, 10: 1741 -
3d
Clader JW. J. Med. Chem. 2004, 47: 1 -
3e
Kvaerno L.Ritter T.Werder M.Hauser H.Carreira EM. Angew. Chem. Int. Ed. 2004, 43: 4653 - For gene activation use, see:
-
3f
Rothstein JD.Patel S.Regan MR.Haenggeli C.Huang YH.Bergles DE.Jin L.Hoberg MD.Vidensky S.Chung DS.Toan SV.Bruijn LI.Su Z.-z.Gupta P.Fisher PB. Nature 2005, 433: 73 - For selected reviews, see:
-
4a
Alcaide B.Almendros P.Aragoncillo C. Chem. Rev. 2007, 107: 4437 -
4b
Alcaide B.Almendros P. Curr. Med. Chem. 2004, 11: 1921 -
4c
Deshmukh ARAS.Bhawal BM.Krishnaswamy D.Govande VV.Shinkre BA.Jayanthi A. Curr. Med. Chem. 2004, 11: 1889 -
4d
Alcaide B.Almendros P. Synlett 2002, 381 -
4e
Palomo C.Aizpurua JM.Ganboa I.Oiarbide M. Synlett 2001, 1813 -
5a
Alcaide B.Almendros P.Cabrero G.Ruiz MP. Chem. Commun. 2008, 615 - For a review on β-lactam aldehydes, see:
-
5b
Alcaide B.Almendros P. Chem. Soc. Rev. 2001, 30: 226 - 6 For a recent review, see:
Togo H.Iida S. Synlett 2006, 2159 -
7a
Yadav JS.Reddy BVS.Reddy MS.Prasad AR. Tetrahedron Lett. 2002, 43: 9703 -
7b
Royer L.De S K.Gibbs RA. Tetrahedron Lett. 2005, 46: 4595 - 8
Alcaide B.Almendros P.Cabrero G.Ruiz MP. J. Org. Chem. 2007, 72: 7980